Here is an excerpt from a terrific LinkedIn post by David Shillingford. NOTE: My comment follows the excerpt.
The trend towards ‘regionalized’ supply chains is reflected in the description here by AstraZeneca‘s CEO Pascal Soriot of a ‘two supply chain’ strategy; one for the ‘east’ and one for the ‘west’.
Almost every company is grappling with the implications of the escalating US-China trade war yet it is a different calculus when China is a large and growing market as well as a manufacturing base. Pascal also notes that R&D will continue to be a global function so that innovations in any market can be leveraged by any other market.
A great ‘companion piece’ to this is the recent and engaging discussion between Gartner‘s Thomas O’Connor and AZ’s Matt Winterman (‘How AstraZeneca Adapts Strategic Decision Making for Resilience’: https://lnkd.in/eSPYzhWa)
My Response:
Regarding regionalized supply chains – they say a picture is worth a thousand words, so rather than writing about lemmings running off a cliff, cats chasing a red dot on the wall, or a pee wee hockey scrum, the following image sums things up nicely.
For further clarification on the above, here is the link to a recent post – https://bit.ly/3LKFXTG
With the above article, I would also like to point out my reference to a 2007 post I wrote on Cluster Development, the Humphrey and Schmitz Governance model, and E.G. Robinson’s book The Structure of Competitive Industry (Cambridge Economic Handbooks, 1958).
AstraZeneca CEO Pascal Soriot has a ‘two supply chain’ strategy: one for the ‘east’ and one for the ‘west. His proposal is not new or innovative; it is just good business, e.g., adaptive strategic decision-making. It is all part of global supply chains’ ever-evolving and shifting nature.
Have we forgotten about the Liverpool cotton exchange of the early 1900s and the emergence and use of agent-based modeling?
My advice: Don’t throw out the umbrella; use it differently.
30
Procurement Insights
AstraZeneca – Don’t Throw Out The Umbrella
Posted on July 30, 2024
0
Here is an excerpt from a terrific LinkedIn post by David Shillingford. NOTE: My comment follows the excerpt.
The trend towards ‘regionalized’ supply chains is reflected in the description here by AstraZeneca‘s CEO Pascal Soriot of a ‘two supply chain’ strategy; one for the ‘east’ and one for the ‘west’.
Almost every company is grappling with the implications of the escalating US-China trade war yet it is a different calculus when China is a large and growing market as well as a manufacturing base. Pascal also notes that R&D will continue to be a global function so that innovations in any market can be leveraged by any other market.
A great ‘companion piece’ to this is the recent and engaging discussion between Gartner‘s Thomas O’Connor and AZ’s Matt Winterman (‘How AstraZeneca Adapts Strategic Decision Making for Resilience’: https://lnkd.in/eSPYzhWa)
My Response:
Regarding regionalized supply chains – they say a picture is worth a thousand words, so rather than writing about lemmings running off a cliff, cats chasing a red dot on the wall, or a pee wee hockey scrum, the following image sums things up nicely.
For further clarification on the above, here is the link to a recent post – https://bit.ly/3LKFXTG
With the above article, I would also like to point out my reference to a 2007 post I wrote on Cluster Development, the Humphrey and Schmitz Governance model, and E.G. Robinson’s book The Structure of Competitive Industry (Cambridge Economic Handbooks, 1958).
AstraZeneca CEO Pascal Soriot has a ‘two supply chain’ strategy: one for the ‘east’ and one for the ‘west. His proposal is not new or innovative; it is just good business, e.g., adaptive strategic decision-making. It is all part of global supply chains’ ever-evolving and shifting nature.
Have we forgotten about the Liverpool cotton exchange of the early 1900s and the emergence and use of agent-based modeling?
My advice: Don’t throw out the umbrella; use it differently.
30
Share this:
Related